Riedl Elena M, König Jochem, Koch Cora, Lieb Klaus
Klinik für Psychiatrie und Psychotherapie, Universitätsmedizin Mainz, Deutschland.
Institut für Medizinische Biometrie, Epidemiologie und Informatik, Universitätsmedizin der Johannes-Gutenberg-Universität Mainz, Deutschland.
Z Evid Fortbild Qual Gesundhwes. 2016;110-111:45-53. doi: 10.1016/j.zefq.2015.12.002. Epub 2016 Jan 13.
Patients can truly expect to be treated by their physicians without undue influences of secondary interests. It is not known what patients in Germany know about relationships between physicians and the pharmaceutical industry and if and how they want to be informed about these relationships.
An information sheet explaining conflicts of interest and a 19-item questionnaire were distributed to 765 patients at various medical offices and hospitals in two German cities. 80 % (n=612) of the patients completed and returned the questionnaires anonymously.
65 % of the patients did not know of conflicts of interest (COI) doctors may have with the pharmaceutical industry. 74 % of the patients would like to know if their doctor had obtained any benefits through contacts with the pharmaceutical industry. 71 % agreed that a disclosure would increase their confidence, and 74 % wanted their physicians to declare COI verbally to them during a consultation. 40 % would prefer a doctor who is not receiving any benefits from the pharmaceutical industry. The desire for disclosure was significantly higher in patients who had an awareness of the problems of COI (OR 4.95; 95 % CI 3.33 - 7.35). However, 35 % of the patients trusted their attending physicians anyway and did not see a need for disclosure of any COI.
The majority of patients, but not all patients want to be informed about COI of their physicians. The best way to do this has yet to be determined.
患者确实期望在不受次要利益不当影响的情况下接受医生治疗。目前尚不清楚德国患者对医生与制药行业之间的关系了解多少，以及他们是否希望以及希望如何了解这些关系。
向德国两个城市的多家医疗机构和医院的765名患者发放了一份解释利益冲突的信息表和一份包含19个项目的问卷。80%（n = 612）的患者匿名填写并返回了问卷。
65%的患者不知道医生可能与制药行业存在利益冲突。74%的患者想知道他们的医生是否通过与制药行业的接触获得了任何利益。71%的患者同意披露会增加他们的信心，74%的患者希望他们的医生在会诊时向他们口头声明利益冲突。40%的患者更喜欢不接受制药行业任何利益的医生。对利益冲突问题有认识的患者对披露的渴望明显更高（比值比4.95；95%置信区间3.33 - 7.35）。然而，35%的患者无论如何都信任他们的主治医生，认为没有必要披露任何利益冲突。
大多数患者，但并非所有患者都希望了解医生的利益冲突情况。实现这一目标的最佳方式尚待确定。
